NORTH
CHICAGO, Ill., June 22,
2023 /PRNewswire/ -- The board of directors of
AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend
of $1.48 per share.
The cash dividend is payable August 15,
2023, to stockholders of record at the close of business on
July 14, 2023.
Since the company's inception in 2013, AbbVie has increased its
dividend by 270 percent. AbbVie is a member of the S&P Dividend
Aristocrats Index, which tracks companies that have annually
increased their dividend for at least 25 consecutive years.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines
that solve serious health issues today and address the medical
challenges of tomorrow. We strive to have a remarkable impact on
people's lives across several key therapeutic areas: immunology,
oncology, neuroscience, eye care, virology and gastroenterology, in
addition to products and services across our Allergan Aesthetics
portfolio. For more information about AbbVie, please visit us at
www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram,
YouTube and LinkedIn.
View original
content:https://www.prnewswire.com/news-releases/abbvie-declares-quarterly-dividend-301858393.html
SOURCE AbbVie